This article examines the profound implications of biodiversity loss and ecosystem service degradation for drug discovery and development.
This article synthesizes the critical role of biodiversity in underpinning all categories of ecosystem services, with a specialized focus on implications for drug discovery and healthcare.
This article synthesizes current scientific understanding of the relationship between biodiversity and ecosystem functioning, with a specific focus on implications for biomedical research and drug discovery.
This article provides a comprehensive comparison of connectivity metrics, a cornerstone of modern computational drug repositioning.
This article provides a comprehensive guide for researchers and conservation scientists on evaluating and enhancing the connectivity of Protected Area Networks (PANs).
This article provides a comprehensive framework for applying cost-benefit analysis (CBA) to drug development mitigation strategies, tailored for researchers, scientists, and development professionals.
This article provides a comprehensive meta-analytic review of corridor effectiveness, synthesizing evidence across ecological and clinical domains.
This article synthesizes findings from major long-term habitat fragmentation experiments, spanning decades and continents, to provide a comprehensive resource for researchers and scientists.
This article provides a comprehensive framework for applying landscape genetics to validate functional connectivity in biological systems, with direct implications for drug discovery and clinical research.
This article provides a comprehensive analysis of strategies for improving matrix permeability to enhance drug dispersal, targeting researchers and drug development professionals.